HK16683A - 21-halogenopregnane compounds - Google Patents

21-halogenopregnane compounds

Info

Publication number
HK16683A
HK16683A HK166/83A HK16683A HK16683A HK 16683 A HK16683 A HK 16683A HK 166/83 A HK166/83 A HK 166/83A HK 16683 A HK16683 A HK 16683A HK 16683 A HK16683 A HK 16683A
Authority
HK
Hong Kong
Prior art keywords
halogenopregnane
compounds
halogenopregnane compounds
Prior art date
Application number
HK166/83A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of HK16683A publication Critical patent/HK16683A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK166/83A 1976-09-29 1983-05-19 21-halogenopregnane compounds HK16683A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU75903A LU75903A1 (fi) 1976-09-29 1976-09-29

Publications (1)

Publication Number Publication Date
HK16683A true HK16683A (en) 1983-05-27

Family

ID=19728370

Family Applications (1)

Application Number Title Priority Date Filing Date
HK166/83A HK16683A (en) 1976-09-29 1983-05-19 21-halogenopregnane compounds

Country Status (24)

Country Link
JP (1) JPS5356652A (fi)
AT (3) AT363197B (fi)
AU (1) AU514200B2 (fi)
BE (1) BE859120A (fi)
CA (1) CA1101410A (fi)
CH (9) CH624967A5 (fi)
CY (1) CY1178A (fi)
DD (1) DD133150A5 (fi)
DE (1) DE2743069C2 (fi)
DK (1) DK146017C (fi)
ES (1) ES462763A1 (fi)
FR (1) FR2366311A1 (fi)
GB (1) GB1563638A (fi)
HK (1) HK16683A (fi)
HU (1) HU175218B (fi)
IE (1) IE46047B1 (fi)
IL (1) IL53012A (fi)
KE (1) KE3258A (fi)
LU (1) LU75903A1 (fi)
MY (1) MY8400092A (fi)
NL (1) NL7710089A (fi)
SE (1) SE436751B (fi)
SG (1) SG3383G (fi)
ZA (1) ZA775800B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
WO1991014700A2 (en) * 1990-03-27 1991-10-03 Schering Corporation PROCESS FOR 9α-HYDROXY STEROID DEHYDRATION
US5972922A (en) * 1990-06-11 1999-10-26 Alcon Laboratories, Inc. Steroids which inhibit angiogenesis
US7098328B2 (en) 2001-11-29 2006-08-29 Taro Pharmaceutical Industries Limited Method for the preparation of 6α-fluoro corticosteroids
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
WO2016205001A1 (en) 2015-06-18 2016-12-22 Valeant Pharmaceuticals North America Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB898292A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
US3644340A (en) * 1970-03-19 1972-02-22 Syntex Corp Preparation of 21-chloro steroids
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Also Published As

Publication number Publication date
ATA691077A (de) 1980-12-15
JPS6214557B2 (fi) 1987-04-02
CA1101410A (en) 1981-05-19
ATA151379A (de) 1980-12-15
DK146017B (da) 1983-05-24
CH625810A5 (en) 1981-10-15
ATA151279A (de) 1980-12-15
DE2743069A1 (de) 1978-03-30
CH631999A5 (en) 1982-09-15
BE859120A (fr) 1978-03-28
IL53012A (en) 1982-05-31
DK256977A (da) 1978-03-30
SE7706673L (sv) 1978-03-30
GB1563638A (en) 1980-03-26
CH625809A5 (en) 1981-10-15
CH632521A5 (en) 1982-10-15
KE3258A (en) 1983-03-04
SE436751B (sv) 1985-01-21
CH632279A5 (en) 1982-09-30
HU175218B (hu) 1980-06-28
AU514200B2 (en) 1981-01-29
AT363203B (de) 1981-07-27
SG3383G (en) 1983-09-09
CH625808A5 (en) 1981-10-15
CH624967A5 (en) 1981-08-31
DE2743069C2 (de) 1987-03-05
CH631998A5 (en) 1982-09-15
IL53012A0 (en) 1977-11-30
AT363197B (de) 1981-07-10
NL7710089A (nl) 1978-03-31
CY1178A (en) 1983-06-10
MY8400092A (en) 1984-12-31
ZA775800B (en) 1978-08-30
JPS5356652A (en) 1978-05-23
FR2366311A1 (fr) 1978-04-28
IE46047B1 (en) 1983-02-09
LU75903A1 (fi) 1978-05-16
AT363202B (de) 1981-07-27
DD133150A5 (de) 1978-12-13
DK146017C (da) 1983-10-24
IE46047L (en) 1978-03-29
CH632000A5 (en) 1982-09-15
AU2914877A (en) 1979-04-05
ES462763A1 (es) 1978-05-16
FR2366311B1 (fi) 1982-12-03

Similar Documents

Publication Publication Date Title
IL48824A0 (en) Thc-type compounds
JPS52151348A (en) Compound
JPS5363424A (en) Bitumious compound
JPS52125197A (en) Transshexahydroopyridooindole compound
JPS5297994A (en) Betaalactummcontaining compounds
JPS5317639A (en) Hexakisazo compounds
JPS5353618A (en) Nnsubstituted biscarbamoylsulfide compound
GB1539364A (en) 11-deoxy-11-oxaprostaglandin compounds
JPS5295689A (en) Betaalactummcontaining compound
JPS5325537A (en) Compound
JPS5359686A (en) Compound
JPS5293772A (en) Indolinospiropyran compound
CY1178A (en) 21-halogenopregnane compounds
JPS5323995A (en) Antiibacterial compound
JPS5321222A (en) Bissbenzoxazolyl compound
JPS52156899A (en) Compound
JPS52111590A (en) Novel cephalospoline compounds
JPS5353692A (en) Antiiworm compound
JPS52102227A (en) Haloalkylphosphate compounds
ZA772175B (en) Oxothia compounds
JPS5285216A (en) Azamethineemetal complex compounds
JPS5353693A (en) Antiiworm compound
JPS5297990A (en) Cephalospoline compounds
JPS52125158A (en) Oxothia compound
GB1542784A (en) Arylorganobromosilicone compounds

Legal Events

Date Code Title Description
PE Patent expired